Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.

Bibliographic Details
Title:	Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.
Authors:	Appleman, Leonard J., Kim, Se Eun, Harris, Wayne B., Pal, Sumanta K., Pins, Michael R., Kolesar, Jill, Agarwal, Neeraj, Parikh, Rahul A., Vaena, Daniel A., Ryan, Christopher W., Hashmi, Mehmood, Costello, Brian A., Cella, David, Dutcher, Janice P., DiPaola, Robert S., Haas, Naomi B., Wagner, Lynne I., Carducci, Michael A.
Source:	Journal of Clinical Oncology; 6/10/2024, Vol. 42 Issue 17, p2061-2070, 17p
Database:	Supplemental Index

More Details
ISSN:	0732183X
DOI:	10.1200/JCO.23.01544
Published in:	Journal of Clinical Oncology
Language:	English